SCRIPTURE CHARITY enters BELLICUM PHARMACEUTICALS, INC with 14.59K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives

SCRIPTURE CHARITY

Filed: 12/2/2021ACC: 0001895948-21-000002

InsiderSCRIPTURE CHARITYCIK 1895948

→

IssuerBELLICUM PHARMACEUTICALS, INCCIK 1358403

Officer· Chief Development Officer

Since Dec 2021

14.59K

Baseline shares

100% direct

14.59K

Direct ownership

1 position

126.80K

Derivative underlying

5 instruments

Security positions

All direct

Non-Derivative Holdings1

Common Stock

Direct

Shares owned14.59K

Total

14.59K direct14.59K

Security Title	Shares Owned	Ownership Type
Common Stock	14.59K	Direct
Total	14.59K	14.59K direct

Derivative Holdings5

Stock Option (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

2.50K

Shares owned

N/A

Exercise price

4.41

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

50K

Shares owned

N/A

Exercise price

2.88

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

19.30K

Shares owned

N/A

Exercise price

1.36

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

20K

Shares owned

N/A

Exercise price

7.13

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

35K

Shares owned

N/A

Exercise price

2.97

Expiration

—

Exercise window

—

Total

Underlying

126.80K

Owned

0.00

Security	Underlying	Exercise Price	Exercise Window	Expiration	Underlying Shares	Shares Owned
Stock Option (right to buy) Direct	Common Stock	4.41	—	—	2.50K	N/A
Stock Option (right to buy) Direct	Common Stock	2.88	—	—	50K	N/A
Stock Option (right to buy) Direct	Common Stock	1.36	—	—	19.30K	N/A
Stock Option (right to buy) Direct	Common Stock	7.13	—	—	20K	N/A
Stock Option (right to buy) Direct	Common Stock	2.97	—	—	35K	N/A
Total					126.80K	0.00